New drug combo tested for Tough-to-Treat brain cancer
Disease control
Recruiting now
This study is testing a new three-drug combination for adults with central nervous system lymphoma that has returned or not responded to prior treatment. The goal is to find a safe and effective dose of the oral drug selinexor when added to standard chemotherapy drugs (methotrexa…
Phase: PHASE1, PHASE2 • Sponsor: Tong Chen, MD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC